{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antiviral drugs", "biochemical methods", "cheminformatics", "coronavirus", "genetic engineering", "medicinal plants (herbal drugs)", "secondary metabolites"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33304368", "DateRevised": {"Year": "2024", "Month": "03", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "16"}], "Language": ["eng"], "ELocationID": ["589998", "10.3389/fpls.2020.589998"], "Journal": {"ISSN": "1664-462X", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in plant science", "ISOAbbreviation": "Front Plant Sci"}, "ArticleTitle": "In Search of Herbal Anti-SARS-Cov2 Compounds.", "Pagination": {"StartPage": "589998", "MedlinePgn": "589998"}, "Abstract": {"AbstractText": ["On March 11, 2020, the World Health Organization (WHO) announced that the spread of the new coronavirus had reached the stage of a pandemic. To date (23.10.2020), there are more than 40 million confirmed cases of the disease in the world, at the same time there is still no effective treatment for the disease. For management and treatment of SARS-Cov2, the development of an antiviral drug is needed. Since the representatives of all human cultures have used medicinal plants to treat viral diseases throughout their history, plants can be considered as sources of new antiviral drug compounds against emerging viruses. The huge metabolic potential of plants allows us to expect discovery of plant compounds for the prevention and treatment of coronavirus infection. This idea is supported by number of papers on the anti-SARS-Cov2 activity of plant extracts and specific compounds in the experiments <i>in silico</i>, <i>in vitro</i>, and <i>in vivo</i>. Here, we summarize information on methods and approaches aimed to search for anti-SARS-Cov2 compounds including cheminformatics, bioinformatics, genetic engineering of viral targets, interacting with drugs, biochemical approaches etc. Our mini-review may be useful for better planning future experiments (including rapid methods for screening compounds for antiviral activity, the initial assessment of the antiviral potential of various plant species in relation to certain pathogens, etc.) and giving a hand to those who are making first steps in this field."], "CopyrightInformation": "Copyright \u00a9 2020 Matveeva, Khafizova and Sokornova."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia."}], "LastName": "Matveeva", "ForeName": "Tatiana", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia."}], "LastName": "Khafizova", "ForeName": "Galina", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology and Biotechnology, All-Russian Institute of Plant Protection, St. Petersburg, Russia."}], "LastName": "Sokornova", "ForeName": "Sofia", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Plant Sci", "NlmUniqueID": "101568200", "ISSNLinking": "1664-462X"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Aanouz I., Belhassan A., El-Khatabi K., Lakhlifi T., El-Ldrissi M., Bouachrine M. (2020). Moroccan medicinal plants as inhibitors against SARS-CoV-2 main protease: computational investigations. J. Biomol. Struct. Dyn. 1-9. 10.1080/07391102.2020.1758790 [Epub ahead of print]", "ArticleIdList": ["10.1080/07391102.2020.1758790", "PMC7212546", "32306860"]}, {"Citation": "Adedeji A. O., Sarafianos S. (2014). Antiviral drugs specific for coronaviruses in preclinical development. Curr. Opin. Virol. 8, 45\u201353. 10.1016/j.coviro.2014.06.002, PMID:", "ArticleIdList": ["10.1016/j.coviro.2014.06.002", "PMC4195804", "24997250"]}, {"Citation": "Alamri M. A., Altharawi A., Alabbas A. B., Alossaimi M. A., Alqahtani S. M. (2020). Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics. ChemRxiv [Preprint]. 10.26434/chemrxiv.12336635.v1", "ArticleIdList": ["10.26434/chemrxiv.12336635.v1", "PMC7415226", "34909058"]}, {"Citation": "Anand K., Ziebuhr J., Wadhwani P., Mesters J. R., Hilgenfeld R. (2003). Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300, 1763\u20131767. 10.1126/science.1085658, PMID:", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "B\u00e1ez-Santos Y. M., St John S. E., Mesecar A. D. (2015). The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. Antivir. Res. 115, 21\u201338. 10.1016/j.antiviral.2014.12.015, PMID:", "ArticleIdList": ["10.1016/j.antiviral.2014.12.015", "PMC5896749", "25554382"]}, {"Citation": "Bevinakoppamath S., Ramachandra S. C., Akila P. (2020). An insight into the use of transgenic animal models for conducting research on coronavirus. Int. J. Health Allied Sci. 9, 18\u201323. 10.4103/ijhas.IJHAS_86_20", "ArticleIdList": ["10.4103/ijhas.IJHAS_86_20"]}, {"Citation": "Boone H. A., Medunjanin D., Sijer\u010di\u0107 A. (2020). Review on potential of phytotherapeutics in fight against COVID-19. Int. J. Innov. Sci. Res. Technol. 5, 481\u2013491."}, {"Citation": "Butcher E. C., Berg E. L., Kunkel E. J. (2004). Systems biology in drug discovery. Nat. Biotechnol. 22, 1253\u20131259. 10.1038/nbt1017, PMID:", "ArticleIdList": ["10.1038/nbt1017", "15470465"]}, {"Citation": "Carter G. T. (2011). Natural products and Pharma 2011: strategic changes spur new opportunities. Nat. Prod. Rep. 28, 1783\u20131789. 10.1039/c1np00033k, PMID:", "ArticleIdList": ["10.1039/c1np00033k", "21909580"]}, {"Citation": "Chen X., Chou C. Y., Chang G. G. (2009). Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme. Antivir. Chem. Chemother. 19, 151\u2013156. 10.1177/095632020901900402, PMID:", "ArticleIdList": ["10.1177/095632020901900402", "19374142"]}, {"Citation": "Chen L., Hu C., Hood M., Zhang X., Zhang L., Kan J., et al. . (2020). Novel combination of vitamin C, curcumin and glycyrrhizic acid potentially regulates immune and inflammatory response associated with coronavirus infections: a perspective from system biology analysis. Nutrients 12:1193. 10.3390/nu12041193, PMID:", "ArticleIdList": ["10.3390/nu12041193", "PMC7230237", "32344708"]}, {"Citation": "Chen L., Li J., Luo C., Liu H., Xu W., Chen G., et al. . (2006). Binding interaction of quercetin-3-\u03b2-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: structure\u2013activity relationship studies reveal salient pharmacophore features. Bioorg. Med. Chem. 14, 8295\u20138306. 10.1016/j.bmc.2006.09.014, PMID:", "ArticleIdList": ["10.1016/j.bmc.2006.09.014", "PMC7125754", "17046271"]}, {"Citation": "Cheriet T., Ben-Bachir B., Thamri O., Seghiri R., Mancini I. (2020). Isolation and biological properties of the natural flavonoids pectolinarin and pectolinarigenin\u2014a review. Antibiotics 9:417. 10.3390/antibiotics9070417, PMID:", "ArticleIdList": ["10.3390/antibiotics9070417", "PMC7400350", "32708783"]}, {"Citation": "Chikhale R. V., Gurav S. S., Patil R. B., Sinha S. K., Prasad S. K., Shakya A., et al. (2020). SARS-Cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. J. Biomol. Struct. Dyn. 1\u201312. 10.1080/07391102.2020.1778539 [Epub ahead of print]", "ArticleIdList": ["10.1080/07391102.2020.1778539", "PMC7332873", "32568012"]}, {"Citation": "Cho J. K., Curtis-Long M. J., Lee K. H., Kim D. W., Ryu H. W., Yuk H. J., et al. . (2013). Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa. Bioorg. Med. Chem. 21, 3051\u20133057. 10.1016/j.bmc.2013.03.027, PMID:", "ArticleIdList": ["10.1016/j.bmc.2013.03.027", "PMC7126831", "23623680"]}, {"Citation": "Chou C. Y., Chien C. H., Han Y. S., Prebanda M. T., Hsieh H. P., Turk B., et al. . (2008). Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biochem. Pharmacol. 75, 1601\u20131609. 10.1016/j.bcp.2008.01.005, PMID:", "ArticleIdList": ["10.1016/j.bcp.2008.01.005", "PMC7092826", "18313035"]}, {"Citation": "Clemente V., D\u2019Arcy P., Bazzaro M. (2020). Deubiquitinating enzymes in coronaviruses and possible therapeutic opportunities for COVID-19. Int. J. Mol. Sci. 21:3492. 10.3390/ijms21103492, PMID:", "ArticleIdList": ["10.3390/ijms21103492", "PMC7278987", "32429099"]}, {"Citation": "Coutard B., Valle C., De Lamballerie X., Canard B., Seidah N., Decroly E. (2020). The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir. Res. 176:104742. 10.1016/j.antiviral.2020.104742, PMID:", "ArticleIdList": ["10.1016/j.antiviral.2020.104742", "PMC7114094", "32057769"]}, {"Citation": "Cragg G. M., Newman D. J. (2013). Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta 1830, 3670\u20133695. 10.1016/j.bbagen.2013.02.008, PMID:", "ArticleIdList": ["10.1016/j.bbagen.2013.02.008", "PMC3672862", "23428572"]}, {"Citation": "Das B., Madhusudhan P., Kashinatham A. (1998). Two efficient methods for the conversion of camptothecin to mappicine ketone, an antiviral lead compound. Tetrahedron Lett. 39, 431\u2013432. 10.1016/S0040-4039(97)10539-1", "ArticleIdList": ["10.1016/S0040-4039(97)10539-1"]}, {"Citation": "Denoeud F., Carretero-Paulet L., Dereeper A., Droc G., Guyot R., Pietrella M., et al. . (2014). The coffee genome provides insight into the convergent evolution of caffeine biosynthesis. Science 345, 1181\u20131184. 10.1126/science.1255274, PMID:", "ArticleIdList": ["10.1126/science.1255274", "25190796"]}, {"Citation": "Dhama K., Karthik K., Khandia R., Munjal A., Tiwari R., Rana R., et al. . (2018). Medicinal and therapeutic potential of herbs and plant metabolites/extracts countering viral pathogens\u2014current knowledge and future prospects. Curr. Drug Metab. 19, 236\u2013263. 10.2174/1389200219666180129145252, PMID:", "ArticleIdList": ["10.2174/1389200219666180129145252", "29380697"]}, {"Citation": "Dhama K., Khan S., Tiwari R., Sircar S., Bhat S., Malik Y. S., et al. (2020). Coronavirus disease 2019-COVID-19. Clin. Microbiol. Rev. 33, e00028\u2013e00020. 10.1128/CMR.00028-20", "ArticleIdList": ["10.1128/CMR.00028-20", "PMC7405836", "32580969"]}, {"Citation": "Divya M., Vijayakumar S., Chen J., Vaseeharan B., Dur\u00e1n-Lara E. F. (2020). A review of south Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19? Microb. Pathog. 104277. 10.1016/j.micpath.2020.104277 [Epub ahead of print]", "ArticleIdList": ["10.1016/j.micpath.2020.104277", "PMC7253980", "32473390"]}, {"Citation": "Drews J. (2000). Drug discovery: a historical perspective. Science 287, 1960\u20131964. 10.1126/science.287.5460.1960, PMID:", "ArticleIdList": ["10.1126/science.287.5460.1960", "10720314"]}, {"Citation": "Erukainure O. L., Mesaik M. A., Atolani O., Muhammad A., Chukwuma C. I., Islam M. S. (2017). Pectolinarigenin from the leaves of Clerodendrum volubile shows potent immunomodulatory activity by inhibiting T-cell proliferation and modulating respiratory oxidative burst in phagocytes. Biomed. Pharmacother. 93, 529\u2013535. 10.1016/j.biopha.2017.06.060, PMID:", "ArticleIdList": ["10.1016/j.biopha.2017.06.060", "28686966"]}, {"Citation": "Ghildiyal R., Prakash V., Chaudhary V. K., Gupta V., Gabrani R. (2020). \u201cPhytochemicals as antiviral agents: recent updates\u201d in Plant-derived bioactives. ed. Swamy M. (Singapore: Springer; )."}, {"Citation": "Ghosh R., Chakraborty A., Biswas A., Chowdhuri S. (2020). Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors\u2014an in silico docking and molecular dynamics simulation study. J. Biomol. Struct. Dyn. 10.1080/07391102.2020.1779818 [Epub ahead of print]", "ArticleIdList": ["10.1080/07391102.2020.1779818", "PMC7332865", "32568613"]}, {"Citation": "Gurib-Fakim A. (2006). Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol. Asp. Med. 27, 1\u201393. 10.1016/j.mam.2005.07.008, PMID:", "ArticleIdList": ["10.1016/j.mam.2005.07.008", "16105678"]}, {"Citation": "Handjieva N., Tersieva L., Popov S., Evstatieva L. (1995). Two iridoid glucosides, 5-O-Menthiafoloylkickxioside and kickxin, from Kickxia Dum. Species. Phytochemistry 39, 925\u2013927. 10.1016/0031-9422(95)00019-4", "ArticleIdList": ["10.1016/0031-9422(95)00019-4"]}, {"Citation": "Hilgenfeld R. (2014). From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J. 281, 4085\u20134096. 10.1111/febs.12936, PMID:", "ArticleIdList": ["10.1111/febs.12936", "PMC7163996", "25039866"]}, {"Citation": "Hisashi Y., Saito K. (2013). Network analysis for gene discovery in plant-specialized metabolism. Plant Cell Environ. 36, 1597\u20131606. 10.1111/pce.12069, PMID:", "ArticleIdList": ["10.1111/pce.12069", "23336321"]}, {"Citation": "Ho K. V., Schreiber K. L., Park J., Vo P. H., Lei Z., Sumner L. W., et al. . (2020). Identification and quantification of bioactive molecules inhibiting pro-inflammatory cytokine production in spent coffee grounds using metabolomics analyses. Front. Pharmacol. 11:229. 10.3389/fphar.2020.00229, PMID:", "ArticleIdList": ["10.3389/fphar.2020.00229", "PMC7073796", "32210815"]}, {"Citation": "Hoopes G. M., Hamilton J. P., Kim J., Zhao D., Wiegert-Riningeer K., Crisovan E., et al. . (2018). Genome assembly and annotation of the medicinal plant Calotropis gigantea, a producer of anticancer and antimalarial cardenolides. G3: GENES, GENOMES, GENETICS 8, 385\u2013391. 10.1534/g3.117.300331, PMID:", "ArticleIdList": ["10.1534/g3.117.300331", "PMC5919723", "29237703"]}, {"Citation": "Huang J., Song W., Huang H., Sun Q. (2020). Pharmacological therapeutics targeting RNA-dependent RNA polymerase, proteinase and spike protein: from mechanistic studies to clinical trials for COVID-19. J. Clin. Med. 9:1131. 10.3390/jcm9041131, PMID:", "ArticleIdList": ["10.3390/jcm9041131", "PMC7231166", "32326602"]}, {"Citation": "Jena A. B., Kanungo N., Nayak V., Chainy G. B. N., Dandapat J. (2020). Catechin and Curcumin interact with corona (2019-nCoV/SARS-CoV2) viral S protein and ACE2 of human cell membrane insights from computational study and implication for intervention. Research square [Preprint]. 10.21203/rs.3.rs-22057/v1", "ArticleIdList": ["10.21203/rs.3.rs-22057/v1"]}, {"Citation": "Jo S., Kim S., Shin D. H., Kim M. S. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzyme Inhib. Med. Chem. 35, 145\u2013151. 10.1080/14756366.2019.1690480, PMID:", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Kajikawa M., Sierro N., Kawaguchi H., Bakaher N., Ivanov N. V., Hashimoto T., et al. . (2017). Genomic insights into the evolution of the nicotine biosynthesis pathway in tobacco. Plant Physiol. 174, 999\u20131011. 10.1104/pp.17.00070, PMID:", "ArticleIdList": ["10.1104/pp.17.00070", "PMC5462024", "28584068"]}, {"Citation": "Kang M., Wu H., Yang Q., Huang L., Hu Q., Ma T., et al. . (2020). A chromosome-scale genome assembly of Isatis indigotica, an important medicinal plant used in traditional Chinese medicine. Hortic. Res. 7:18. 10.1038/s41438-020-0240-5, PMID:", "ArticleIdList": ["10.1038/s41438-020-0240-5", "PMC6994597", "32025321"]}, {"Citation": "Katsuyama Y., Matsuzawa M., Funa N., Horinouchi S. (2007). In vitro synthesis of curcuminoids by type III polyketide synthase from Oryza sativa. J. Biol. Chem. 282, 37702\u201337709. 10.1074/jbc.M707569200, PMID:", "ArticleIdList": ["10.1074/jbc.M707569200", "17932040"]}, {"Citation": "Krupanidhi S., Abraham Peele K., Venkateswarulu T. C., Ayyagari V. S., Nazneen Bobby M., John Babu D., et al. (2020). Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study. J. Biomol. Struct. Dyn. 1\u20135. 10.1080/07391102.2020.1787226 [Epub ahead of print]", "ArticleIdList": ["10.1080/07391102.2020.1787226", "PMC7441789", "32627715"]}, {"Citation": "Kuo C. J., Chi Y. H., Hsu J. T., Liang P. H. (2004). Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate. Biochem. Biophys. Res. Commun. 318, 862\u2013867. 10.1016/j.bbrc.2004.04.098, PMID:", "ArticleIdList": ["10.1016/j.bbrc.2004.04.098", "PMC7134607", "15147951"]}, {"Citation": "Li S. Y., Chen C., Zhang H. Q., Guo H. Y., Wang H., Wang L., et al. . (2005). Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir. Res. 67, 18\u201323. 10.1016/j.antiviral.2005.02.007, PMID:", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Lin M. H., Moses D. C., Hsieh C. H., Cheng S. C., Chen Y. H., Sun C. Y., et al. . (2018). Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. Antivir. Res. 150, 155\u2013163. 10.1016/j.antiviral.2017.12.015, PMID:", "ArticleIdList": ["10.1016/j.antiviral.2017.12.015", "PMC7113793", "29289665"]}, {"Citation": "Lin C. -W., Tsai C. -H., Tsai F. -J., Chen P. J., Lai C. -C., Wan L., et al. . (2004). Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs. FEBS Lett. 574, 131\u2013137. 10.1016/j.febslet.2004.08.017, PMID:", "ArticleIdList": ["10.1016/j.febslet.2004.08.017", "PMC7127318", "15358553"]}, {"Citation": "Lin C. -W., Tsai F. -J., Tsai C. -H., Lai C. -C., Wan L., Ho T. -Y., et al. . (2005). Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antivir. Res. 68, 36\u201342. 10.1016/j.antiviral.2005.07.002, PMID:", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Lutz C., Maher L., Lee C., Kang W. (2020). COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice. Hum. Genomics 14:20. 10.1186/s40246-020-00272-6, PMID:", "ArticleIdList": ["10.1186/s40246-020-00272-6", "PMC7269898", "32498696"]}, {"Citation": "Mani J. S., Johnson J. B., Steel J. C., Broszczak D. A., Neilsen P. M., Walsh K. B., et al. . (2020). Natural product-derived phytochemicals as potential agents against coronaviruses: a review. Virus Res. 284:197989. 10.1016/j.virusres.2020.197989, PMID:", "ArticleIdList": ["10.1016/j.virusres.2020.197989", "PMC7190535", "32360300"]}, {"Citation": "McCray P. B., Jr., Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., et al. . (2007). Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81, 813\u2013821. 10.1128/JVI.02012-06, PMID:", "ArticleIdList": ["10.1128/JVI.02012-06", "PMC1797474", "17079315"]}, {"Citation": "Menachery V. D., Yount B. L., Jr., Sims A. C., Debbink K., Agnihothram S. S., Gralinski L. E., et al. . (2016). SARS-like WIV1-CoV poised for human emergence. Proc. Natl. Acad. Sci. U. S. A. 113, 3048\u20133053. 10.1073/pnas.1517719113, PMID:", "ArticleIdList": ["10.1073/pnas.1517719113", "PMC4801244", "26976607"]}, {"Citation": "Mondal S., De N., Pal A. (2020). Topological indices of some chemical structures applied for the treatment of COVID-19 patients. Polycycl. Aromat. Compd. 1\u201315. 10.1080/10406638.2020.1770306", "ArticleIdList": ["10.1080/10406638.2020.1770306"]}, {"Citation": "Mukherjee P. K. (2019). \u201cAntiviral evaluation of herbal drugs\u201d in Quality control and evaluation of herbal drugs. ed. Morrissey K. (Cambridge, MA, USA: Elsevier; ), 599\u2013628."}, {"Citation": "Mumtaz A., Ashfaq U. A., ul Qamar M. T., Anwar F., Gulzar F., Ali M. A., et al. . (2017). MPD3: a useful medicinal plants database for drug designing. Nat. Prod. Res. 31, 1228\u20131236. 10.1080/14786419.2016.1233409, PMID:", "ArticleIdList": ["10.1080/14786419.2016.1233409", "27681445"]}, {"Citation": "Murck H. (2020). Symptomatic protective action of glycyrrhizin (Licorice) in COVID-19 infection? Front. Immunol. 11:1239. 10.3389/fimmu.2020.01239, PMID:", "ArticleIdList": ["10.3389/fimmu.2020.01239", "PMC7270278", "32574273"]}, {"Citation": "Nguyen T. T. H., Woo H. -J., Kang H. -K., Nguyen V. D., Kim D. -W., Ahn S. -A., et al. . (2012). Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol. Lett. 34, 831\u2013838. 10.1007/s10529-011-0845-8, PMID:", "ArticleIdList": ["10.1007/s10529-011-0845-8", "PMC7087583", "22350287"]}, {"Citation": "Niraj S., Varsha S. (2020). A review on scope of immuno-modulatory drugs in Ayurveda for prevention and treatment of Covid-19. Plant Sci. Today 7, 417\u2013423. 10.14719/pst.2020.7.3.831", "ArticleIdList": ["10.14719/pst.2020.7.3.831"]}, {"Citation": "Osbourn A. (2010). Secondary metabolic gene clusters: evolutionary toolkits for chemical innovation. Trends Genet. 26, 449\u2013457. 10.1016/j.tig.2010.07.001, PMID:", "ArticleIdList": ["10.1016/j.tig.2010.07.001", "20739089"]}, {"Citation": "Park J. Y., Jeong H. J., Kim J. H., Kim Y. M., Park S. J., Kim D., et al. . (2012a). Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biol. Pharm. Bull. 35, 2036\u20132042. 10.1248/bpb.b12-00623, PMID:", "ArticleIdList": ["10.1248/bpb.b12-00623", "22971649"]}, {"Citation": "Park J. Y., Kim J. H., Kim Y. M., Jeong H. J., Kim D. W., Park K. H., et al. . (2012b). Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg. Med. Chem. 20, 5928\u20135935. 10.1016/j.bmc.2012.07.038, PMID:", "ArticleIdList": ["10.1016/j.bmc.2012.07.038", "PMC7127169", "22884354"]}, {"Citation": "Park J. -Y., Ko J. -A., Kim D. W., Kim Y. M., Kwon H. -J., Jeong H. J., et al. . (2016). Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J. Enzyme Inhib. Med. Chem. 31, 23\u201330. 10.3109/14756366.2014.1003215, PMID:", "ArticleIdList": ["10.3109/14756366.2014.1003215", "25683083"]}, {"Citation": "Park J. Y., Yuk H. J., Ryu H. W., Lim S. H., Kim K. S., Park K. H., et al. . (2017). Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J. Enzyme Inhib. Med. Chem. 32, 504\u2013512. 10.1080/14756366.2016.1265519, PMID:", "ArticleIdList": ["10.1080/14756366.2016.1265519", "PMC6010046", "28112000"]}, {"Citation": "Perlman S., Netland J. (2009). Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7, 439\u2013450. 10.1038/nrmicro2147, PMID:", "ArticleIdList": ["10.1038/nrmicro2147", "PMC2830095", "19430490"]}, {"Citation": "Prasanth D. S. N. B. K., Murahari M., Chandramohan V., Panda S. P., Atmakuri L. R., Guntupalli C. (2020). In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. J. Biomol. Struct. Dyn. 10.1080/07391102.2020.1779129 [Epub ahead of print]", "ArticleIdList": ["10.1080/07391102.2020.1779129", "PMC7332870", "32567989"]}, {"Citation": "Ren X., Shao X. X., Li X. X., Jia X. H., Song T., Zhou W. Y., et al. . (2020). Identifying potential treatments of COVID-19 from traditional Chinese medicine (TCM) by using a data-driven approach. J. Ethnopharmacol. 258:112932. 10.1016/j.jep.2020.112932, PMID:", "ArticleIdList": ["10.1016/j.jep.2020.112932", "PMC7196535", "32376368"]}, {"Citation": "Riva L., Yuan S., Yin X., Martin-Sancho L., Matsunaga N., Pache L., et al. . (2020). Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 586, 113\u2013119. 10.1038/s41586-020-2577-1, PMID:", "ArticleIdList": ["10.1038/s41586-020-2577-1", "PMC7603405", "32707573"]}, {"Citation": "Santos R., Ursu O., Gaulton A., Bento A. P., Donadi R. S., Bologa C. G., et al. . (2016). A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov. 16, 19\u201334. 10.1038/nrd.2016.230, PMID:", "ArticleIdList": ["10.1038/nrd.2016.230", "PMC6314433", "27910877"]}, {"Citation": "Sun D. -D., Dong W., Li X., Zhang H. -Q. (2010). Indole alkaloids from the roots of Isatis ingigotica and their antiherpes simplex virus type 2 (HSV-2) activity in vitro. Chem. Nat. Compd. 46, 763\u2013766. 10.1007/s10600-010-9735-x", "ArticleIdList": ["10.1007/s10600-010-9735-x"]}, {"Citation": "Szajdak L. W. (ed.) (2016). \u201cIntroduction: biologically active compounds\u201d in Bioactive compounds in agricultural soils. (Cham: Springer; )."}, {"Citation": "Tai W., He L., Zhang X., Pu J., Voronin D., Jiang S., et al. . (2020). Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 17, 613\u2013620. 10.1038/s41423-020-0400-4, PMID:", "ArticleIdList": ["10.1038/s41423-020-0400-4", "PMC7091888", "32203189"]}, {"Citation": "Tallei T. E., Tumilaar S. G., Niode N. J., Fatimawali F., Kepel B. J., Idroes R., et al. (2020). Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors a molecular docking study. Preprints [Preprint], 2020040102. 10.20944/preprints202004.0102.v1", "ArticleIdList": ["10.20944/preprints202004.0102.v1", "PMC7773461", "33425427"]}, {"Citation": "Theerawatanasirikul S., Kuo C. J., Phetcharat N., Lekcharoensuk P. (2020). In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus. Antivir. Res. 174:104697. 10.1016/j.antiviral.2019.104697, PMID:", "ArticleIdList": ["10.1016/j.antiviral.2019.104697", "PMC7114316", "31863793"]}, {"Citation": "Tripathi M. K., Singh P., Sharma S., Singh T. P., Ethayathulla A. S., Kaur P. (2020). Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. J. Biomol. Struct. Dyn. 1\u201314. 10.1080/07391102.2020.1790425 [Epub ahead of print]", "ArticleIdList": ["10.1080/07391102.2020.1790425", "PMC7441797", "32643552"]}, {"Citation": "Tseng C. T., Huang C., Newman P., Wang N., Narayanan K., Watts D. M., et al. . (2007). Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 virus receptor. J. Virol. 81, 1162\u20131173. 10.1128/JVI.01702-06, PMID:", "ArticleIdList": ["10.1128/JVI.01702-06", "PMC1797529", "17108019"]}, {"Citation": "van Dorp L., Acman M., Richard D., Shaw L. P., Ford C. E., Ormond L., et al. . (2020). Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect. Genet. Evol. 83:104351. 10.1016/j.meegid.2020.104351, PMID:", "ArticleIdList": ["10.1016/j.meegid.2020.104351", "PMC7199730", "32387564"]}, {"Citation": "Vellingiri B., Jayaramayya K., Iyer M., Narayanasamy A., Govindasamy V., Giridharan B., et al. . (2020). COVID-19: a promising cure for the global panic. Sci. Total Environ. 725:138277. 10.1016/j.scitotenv.2020.138277, PMID:", "ArticleIdList": ["10.1016/j.scitotenv.2020.138277", "PMC7128376", "32278175"]}, {"Citation": "World Health Organization (WHO)  (2020). Coronavirus disease (COVID-2019) situation reports. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (Accessed October 19, 2020)."}, {"Citation": "Wrapp D., Wang N., Corbett K. S., Goldsmith J. A., Hsieh C. -L., Abiona O., et al. . (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263. 10.1126/science.abb2507, PMID:", "ArticleIdList": ["10.1126/science.abb2507", "PMC7164637", "32075877"]}, {"Citation": "Xu X., Chen P., Wang J., Feng J., Zhou H., Li X., et al. . (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci. China Life Sci. 63, 457\u2013460. 10.1007/s11427-020-1637-5, PMID:", "ArticleIdList": ["10.1007/s11427-020-1637-5", "PMC7089049", "32009228"]}, {"Citation": "Yuldashev M. P., Malikov V. M., Batirov \u00c9. K. (1996). Flavonoids of the epigeal part of Kickxia elatine. Chem. Nat. Compd. 32, 30\u201332. 10.1007/BF01373784", "ArticleIdList": ["10.1007/BF01373784"]}, {"Citation": "Zhang Y. -Z., Holmes E. C. (2020). Commentary a genomic perspective on the origin and emergence of SARS-CoV-2. Cell 181, 223\u2013227. 10.1016/j.cell.2020.03.035, PMID:", "ArticleIdList": ["10.1016/j.cell.2020.03.035", "PMC7194821", "32220310"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., et al. . (2020b). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science 368, 409\u2013412. 10.1126/science.abb3405, PMID:", "ArticleIdList": ["10.1126/science.abb3405", "PMC7164518", "32198291"]}, {"Citation": "Zhang D. H., Wu K. L., Zhang X., Deng S. Q., Peng B. (2020a). In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J. Integr. Med. 18, 152\u2013158. 10.1016/j.joim.2020.02.005, PMID:", "ArticleIdList": ["10.1016/j.joim.2020.02.005", "PMC7102521", "32113846"]}, {"Citation": "Zidorn C. (2019). Plant chemophenetics\u2014a new term for plant chemosystematics/plant chemotaxonomy in the macro-molecular era. Phytochemistry 163, 147\u2013148. 10.1016/j.phytochem.2019.02.013, PMID:", "ArticleIdList": ["10.1016/j.phytochem.2019.02.013", "30846237"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "7", "Day": "31"}, {"Year": "2020", "Month": "10", "Day": "27"}, {"Year": "2020", "Month": "12", "Day": "11", "Hour": "6", "Minute": "2"}, {"Year": "2020", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "11", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["33304368", "PMC7701093", "10.3389/fpls.2020.589998"]}}], "PubmedBookArticle": []}